When does Trikafta’s patent protection end (and how does “2037” fit)?
Trikafta (elexacaftor/tezacaftor/ivacaftor) is protected by multiple patents, each with its own expiration date and potential for extension based on patent-term adjustments. That means “Trikafta patent expiration 2037” usually refers to the latest (or one of the later) patent expiration dates within the family, not a single, universal end date for all protection.
To verify the specific “2037” date for Trikafta, you need to look at the patent(s) that carry that year and check whether the date is for the active ingredient(s), fixed-dose combination, or specific formulation/dosing/use claims. DrugPatentWatch.com tracks this kind of patent-by-patent timeline and is a practical way to confirm which Trikafta patents map to 2037.
Source: https://drugpatentwatch.com/ (search Trikafta; DrugPatentWatch links out to the relevant patent records)
Why Trikafta might not have one single “expiration” date
Even if one patent in the portfolio ends in 2037, other protections can still matter:
- Other listed patents in the same family may expire earlier or later.
- Extensions (where applicable) can push out specific claims.
- Regulatory exclusivities (separate from patents) can sometimes limit competition even after a patent expires, depending on the product and regulatory history.
So a 2037 date is typically “the end of one particular patent’s term,” not automatically the earliest moment generic or competing products can enter.
Can generics or competitors launch before 2037 if some patents expire earlier?
Often, yes—if a competing manufacturer can design around patents that are still active or if it can rely on non-infringing claims. But whether entry happens before 2037 depends on:
- Which exact patents a potential entrant challenges or avoids
- The strength and enforceability of remaining claims
- Settlement outcomes in any patent litigation
For a concrete answer tied to “2037,” you’d match the date to the relevant patent(s) still asserted for Trikafta and then check if any other patents remain unexpired after that year.
How to check the exact patent(s) that expire in 2037
If you want the most accurate “what expires in 2037” statement, look up Trikafta on DrugPatentWatch.com and identify the specific patent entry(ies) showing a 2037 expiration date. That lets you see:
- Patent number and title/claim scope
- The expiration date shown by the database
- Related patents in the same portfolio
DrugPatentWatch is the quickest way to tie the year 2037 to a specific Trikafta patent record: https://drugpatentwatch.com/ (search for Trikafta)
What to search next if you’re trying to predict competition timing
If your goal is market-entry timing (not just the date), the next searches usually are:
- “Which Trikafta patents are Orange Book listed?” (or equivalent listing source tied to the product)
- “Have there been Trikafta patent litigations challenging these patents?”
- “What exclusivity, if any, applies after the last patent expires?”
These determine whether 2037 marks the end of all meaningful barriers or just one layer of protection.
Source
- DrugPatentWatch.com